OX-68

Reactivity: Anti-CD4, rat, NOTE: Both the cell line and DNA from the cell line may be available for this product. Please choose -1VL or VIAL for cells, or -DNA-5UG for DNA., 94011007

• UNSPSC Code: 41106514
• Biological source: Mouse x Mouse Hybridoma
• Isotype: IgG2a
• Technique(s): cell culture | mammalian: suitable
• Myeloma: NS0
• Reactivity: Anti-CD4, rat

Eigenschaften

• biological source: Mouse x Mouse Hybridoma
• manufacturer/tradename: ECACC
• packaging: tube of 5 μg 94011007-DNA-5UG, pkg of vial of cells 94011007-1VL
• ImmunoDon: BALB/c mouse spleen
• Myeloma: NS0
• Reactivity: Anti-CD4, rat
• technique(s): cell culture | mammalian: suitable
• isotype: IgG2a
• shipped in: dry ice
• storage temp.: −196°C

Beschreibung

Immunogen

Recombinant soluble rat CD4

Application

Affinity purification of recombinant chainmeric proteins carrying a CD4 tag

Biochem/physiol Actions

Mouse NS0 x Mouse BALB/c spleen

The antibody is directed against domains 3 or 4 of the rat CD4 molecule.

Preparation Note

Maintain cultures between 1-5x100,000 cells/ml; 5% CO₂; 37°C.

RPMI 1640 + 2mM glutamine + 10% Foetal Bovine Serum (FBS)

Other Notes

Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.

This cell line is part of the European Collection of Authenticated Cell Cultures (ECACC), an international repository managed by the United Kingdom Health Security Agency (UKHSA). Use of this product by commercial organizations may require a license agreement. Commercial customers will be contacted by cellscreening@merckgroup.com to provide further information after the order request is submitted. Any other use of these products is prohibited without the express written permission of UKHSA. Inquiries regarding authorized use of this cell line or its genomic DNA may be directed to culturecollections@ukhsa.gov.uk.

Disclaimer

This cell line has special release conditions: Commercial organisations are required to complete the ′Cell Line Release Authorisation for Research Use in Commercial Organisations′ release conditions form.